Abrdn PLC Incyte Corp Transaction History

Abrdn PLC

$53.3 Billion
Q3 2024

A detailed history of Abrdn PLC transactions in Incyte Corp stock. As of the latest transaction made, Abrdn PLC holds 66,238 shares of INCY stock, worth $5.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

66,238

Previous 63,903 3.65%

Holding current value

$5.03 Million

Previous $3.87 Million 13.04%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$57.33 - $68.61 $133,865 - $160,204	2,335 Added 3.65%	66,238 $4.38 Million
Q2 2024 Aug 09, 2024	SELL	$51.18 - $63.75 $4.22 Million - $5.26 Million	-82,477 Reduced 56.34%	63,903 $3.87 Million
Q1 2024 May 08, 2024	SELL	$56.55 - $66.59 $2,657 - $3,129	-47 Reduced 0.03%	146,380 $8.34 Million
Q4 2023 Jan 31, 2024	BUY	$52.16 - $64.19 $4.05 Million - $4.98 Million	77,574 Added 112.67%	146,427 $9.19 Million
Q3 2023 Nov 06, 2023	SELL	$57.77 - $65.93 $157,712 - $179,988	-2,730 Reduced 3.81%	68,853 $3.98 Million
Q2 2023 Jun 20, 2024	SELL	$60.95 - $75.51 $33,522 - $41,530	-550 Reduced 0.76%	71,583 $4.46 Million
Q2 2023 Aug 04, 2023	SELL	$60.95 - $75.51 $33,522 - $41,530	-550 Reduced 0.76%	71,583 $4.46 Million
Q1 2023 Jun 20, 2024	BUY	$70.23 - $86.01 $1.56 Million - $1.91 Million	22,176 Added 44.39%	72,133 $5.21 Million
Q1 2023 Apr 28, 2023	BUY	$70.23 - $86.01 $1.56 Million - $1.91 Million	22,176 Added 44.39%	72,133 $5.21 Million
Q4 2022 Jun 20, 2024	SELL	$67.18 - $84.11 $6.48 Million - $8.11 Million	-96,423 Reduced 65.87%	49,957 $4.01 Million
Q4 2022 Feb 09, 2023	BUY	$67.18 - $84.11 $359,547 - $450,156	5,352 Added 12.0%	49,957 $4.01 Million
Q3 2022 Nov 10, 2022	SELL	$66.18 - $82.86 $3,441 - $4,308	-52 Reduced 0.12%	44,605 $2.97 Million
Q2 2022 Aug 05, 2022	SELL	$66.18 - $83.18 $106,880 - $134,335	-1,615 Reduced 3.49%	44,657 $3.37 Million
Q1 2022 May 04, 2022	SELL	$66.02 - $79.71 $574,638 - $693,795	-8,704 Reduced 15.83%	46,272 $3.68 Million
Q4 2021 Feb 08, 2022	SELL	$63.34 - $74.11 $187,359 - $219,217	-2,958 Reduced 5.11%	54,976 $4.04 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $219,606 - $268,695	-3,198 Reduced 5.23%	57,934 $3.99 Million
Q2 2021 Aug 10, 2021	SELL	$79.87 - $87.53 $192,965 - $211,472	-2,416 Reduced 3.8%	61,132 $5.14 Million
Q1 2021 May 06, 2021	BUY	$76.02 - $100.5 $293,969 - $388,633	3,867 Added 6.48%	63,548 $5.17 Million
Q4 2020 Feb 10, 2021	BUY	$80.74 - $97.7 $282,590 - $341,950	3,500 Added 6.23%	59,681 $5.19 Million
Q3 2020 Oct 21, 2020	SELL	$85.07 - $109.69 $649,679 - $837,702	-7,637 Reduced 11.97%	56,181 $5.04 Million
Q2 2020 Aug 10, 2020	SELL	$74.18 - $108.93 $505,462 - $742,249	-6,814 Reduced 9.65%	63,818 $6.64 Million
Q1 2020 May 13, 2020	BUY	$63.18 - $85.97 $31,590 - $42,985	500 Added 0.71%	70,632 $5.18 Million
Q4 2019 Feb 18, 2020	BUY	$73.04 - $95.72 $11,175 - $14,645	153 Added 0.22%	70,132 $6.12 Million
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $33,205 - $39,453	-456 Reduced 0.65%	69,979 $5.19 Million
Q2 2019 Aug 13, 2019	SELL	$73.52 - $88.7 $67,197 - $81,071	-914 Reduced 1.28%	70,435 $5.98 Million
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $1.61 Million - $2.23 Million	25,300 Added 54.94%	71,349 $6.14 Million
Q4 2018 Feb 12, 2019	SELL	$58.5 - $69.94 $6,552 - $7,833	-112 Reduced 0.24%	46,049 $2.87 Million
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $312,208 - $375,306	5,056 Added 12.3%	46,161 $3.19 Million
Q2 2018 Aug 09, 2018	BUY	$60.85 - $83.98 $615,071 - $848,869	10,108 Added 32.61%	41,105 $2.76 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $90,037 - $109,462	-1,084 Reduced 3.38%	30,997 $2.58 Million
Q4 2017 Feb 12, 2018	BUY	$93.56 - $116.6 $46,873 - $58,416	501 Added 1.59%	32,081 $3.04 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $3.45 Million - $4.37 Million	31,580	31,580 $3.69 Million

Others Institutions Holding INCY

# of Institutions

641

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account